RecruitingNot ApplicableNCT06435546

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers: a Pilot Study

Sponsor

Institut de Cancérologie de Lorraine

Enrollment

200 participants

Start Date

Jun 4, 2024

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Prostate Cancer

Summary

AdOTAC is a pilot study, open, prospective, single-center, one-arm. The 200 patients will be included. Patient is included at Day 0. The included patient will have the opportunity to complete the self-questionnaires either at the ICL on Day 0, or at home up to 10 days after the date of inclusion in the study. Blood samples are collected the day of enrolment (Day 0) in order to measure the following biological markers: ferritin, serum iron, TSAT, albumin, and haemoglobin, except if performed as part of routine care in the previous 6 weeks.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how well patients with advanced breast or prostate cancer stick to taking their oral (pill-form) cancer medications and what factors affect their ability to follow their treatment plan. **You may be eligible if...** - You are 18 or older with advanced breast cancer or advanced prostate cancer that cannot be surgically removed - You are currently on oral hormone therapy or oral targeted therapy for your cancer - You have been on your oral cancer medication for at least 3 months - You are covered by social security and can read/speak French **You may NOT be eligible if...** - Your cancer is early-stage or localized - Your life expectancy is less than 3 months - Your cancer is currently progressing - You are receiving intravenous or certain oral chemotherapy drugs - You are enrolled in another trial involving an experimental drug - You are unable to read or speak French Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood samples

Ferritin, Transferrin Saturation (TSAT), Serum iron, Haemoglobin, Albumin

OTHERAdherence to anti-cancer therapies questionnaires

GIRERD questionnaire, AdOT questionnaire, Use of social networks and alternatives and complementary medicines using patient questionnaire, EORTC QLQC30, HADS, MNA, MSPSS